Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jan 7, 2019; 25(1): 138-150
Published online Jan 7, 2019. doi: 10.3748/wjg.v25.i1.138
Table 3 Univariate and multivariate Cox regression analyses of prognostic factors for overall survival in pancreatic cancer
PredictorUnivariate analysis
Multivariate analysis
HR95%CIP-valueHR95%CIP-value
Age, < 60 vs ≥ 600.8180.798-1.0170.792
Gender (female vs male)0.9280.781-1.1300.952
Differentiation (well vs moderate vs poor)1.0450.873-1.1860.134
Ethnic group (Han/Zhuang/Li)0.9170.834-1.0480.866
TNM stage (I/II vs III/IV)1.4521.215-1.475< 0.0011.1481.031-1.2680.011
Lymph node metastasis (negative vs positive)1.2871.048-1.3640.0071.1981.036-1.3800.017
Neural invasion (negative vs positive)1.0080.781-1.1550.949
Distant metastasis (negative vs positive)1.4261.236-1.710< 0.0011.5211.256-1.887< 0.001
CTC, < 6 vs ≥ 61.8491.717-2.238< 0.0011.8511.637-2.173< 0.001